Quantum
Home > Boards > US Listed > Medical - Healthcare >

ReShape Life Sciences (RSLS)

RSLS RSS Feed
Add RSLS Price Alert      Hide Sticky   Hide Intro
Moderator: PennystockID2017, stockmoneybaby, SC777
Search This Board: 
Last Post: 11/12/2018 1:00:24 PM - Followers: 67 - Board type: Free - Posts Today: 40

ReShape Lifesciences™ 

https://www.reshapelifesciences.com/

ReShape Lifesciences™ is a medical device company focused on technologies to treat obesity and metabolic diseases. The FDA-approved ReShape Balloon™ System involves a non-surgical weight loss procedure that uses advanced balloon technology designed to take up room in the stomach to help people with a 30-40 kg/m2 Body Mass Index (BMI) and at least one co-morbidity lose weight. ReShape vBloc™ Therapy, delivered by an FDA-approved pacemaker-like device called the ReShape vBloc System, is designed to help patients with a 40-45 kg/m2, or a 35-39.9 kg/m2 BMI and at least one co-morbidity feel full and eat less by intermittently blocking hunger signals on the vagus nerve. The ReShape Vest™ System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery, and is intended to enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.

ReShape Lifesciences was incorporated in Minnesota in December 2002 under the name Beta Medical, Inc. In 2003, the Company changed its name to EnteroMedics Inc. and in 2004 reincorporated in Delaware. EnteroMedics began trading on the NASDAQ Stock Market on November 15, 2007.   The Company acquired ReShape Medical, Inc. in October 2017 and subsequently changed its name to ReShape Lifesciences, Inc. 

Financials http://ir.reshapelifesciences.com/static-files/cefa86e6-3998-4cb2-b8d8-c5447d7383b5

PART I – FINANCIAL INFORMATION ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS RESHAPE LIFESCIENCES INC. Condensed Consolidated Balance Sheets (Unaudited) June 30, December 31, 2018 2017 ASSETS Current assets: Cash and cash equivalents $ 1,863,217 $ 10,163,208 Accounts receivable (net of allowance for bad debts of $228,165 and $155,872 at June 30, 2018 and December 31, 2017) 446,027 488,613 Inventory 2,101,017 2,817,112 Prepaid expenses and other current assets 919,543 467,783 Total current assets 5,329,804 13,936,716 Property and equipment, net 303,206 438,621 Goodwill — 27,186,620 Other intangible assets, net 44,802,230 46,152,577 Other assets 76,827 990,015 Total assets $ 50,512,067 $ 88,704,549 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 4,201,239 $ 1,088,271 Accrued expenses 4,499,875 5,955,518 Total current liabilities 8,701,114 7,043,789 Deferred income taxes 2,700,681 5,292,291 Common stock warrant liability 74 1,600 Total liabilities 11,401,869 12,337,680 Commitments and contingencies (Note 7) Stockholders’ equity: Preferred stock, 5,000,000 shares authorized: Series B convertible preferred stock, $0.01 par value; 20,000 shares issued and 2,957 and 6,055 shares outstanding at June 30, 2018 and December 31, 2017, respectively 30 61 Series C convertible preferred stock, $0.01 par value; 187,772 shares issued and 95,388 shares outstanding at June 30, 2018 and December 31, 2017 954 954 Series D convertible preferred stock, $0.01 par value; 6,000 shares issued and 4,750 and zero shares outstanding at June 30, 2018 and December 31, 2017 48 — Common stock, $0.01 par value; 275,000,000 shares authorized at June 30, 2018 and December 31, 2017; 3,610,009 and 2,063,808 shares issued and outstanding at June 30, 2018 and December 31, 2017 36,100 20,640 Additional paid-in capital 424,158,496 411,104,568 Accumulated deficit (385,085,430) (334,759,354) Total stockholders’ equity 39,110,198 76,366,869 Total liabilities and stockholders’ equity $ 50,512,067 $ 88,704,549 See accompanying notes to condensed consolidated financial statements.

RESHAPE LIFESCIENCES INC. Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Product sales $ 633,554 $ 93,060 $ 1,574,985 $ 133,100 Other revenue 19,815 — 28,382 — Total revenue 653,369 93,060 1,603,367 133,100 Cost of revenue 634,774 54,472 1,463,731 83,995 Gross profit 18,595 38,588 139,636 49,105 Operating expenses: Selling, general and administrative 6,710,518 5,560,787 16,756,075 11,489,773 Research and development 2,439,337 1,352,075 5,126,856 2,476,488 Goodwill impairment 27,186,620 — 27,186,620 — Total operating expenses 36,336,475 6,912,862 49,069,551 13,966,261 Operating loss (36,317,880) (6,874,274) (48,929,915) (13,917,156) Other income (expense): Interest income 263 — 674 100 Interest expense — — (2,735) — Change in value of warrant liability 369 34,395 1,494 (288,735) Other, net (142,145) (298) (144,416) (1,198) Loss before income taxes (36,459,393) (6,840,177) (49,074,898) (14,206,989) Income tax benefit 1,208,560 — 2,590,613 — Net loss $ (35,250,833) $ (6,840,177) $ (46,484,285) $ (14,206,989) Adjustment for convertible preferred stock and warrants (3,841,790) — (3,841,790) — Net loss attributable to common shareholders (39,092,623) (6,840,177) (50,326,075) (14,206,989) Net loss per share—basic and diluted $ (15.78) $ (13.68) $ (22.14) $ (32.13) Shares used to compute basic and diluted net loss per share 2,477,910 500,114 2,273,160 442,191






The Company trades on the NASDAQ under the ticker symbol RSLS.http://ir.reshapelifesciences.com/financial-information/sec-filings



As of August 10, 2018, 9,013,421 shares of the registrant’s Common Stock were outstanding.

Quantum
RSLS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RSLS News: Current Report Filing (8-k) 11/07/2018 04:05:51 PM
RSLS News: Current Report Filing (8-k) 11/05/2018 04:09:06 PM
RSLS News: Current Report Filing (8-k) 10/30/2018 05:24:16 PM
RSLS News: Amended Statement of Ownership (sc 13g/a) 10/12/2018 04:01:27 PM
RSLS News: Proxy Statement (definitive) (def 14a) 10/09/2018 08:35:54 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2327   Or short selling ? Manipulation ? WhAT ELSE ! allezlOM 11/12/18 01:00:24 PM
#2326   so your here for the kids around 12 stockyupydowny 11/12/18 12:44:32 PM
#2325   2.14 does somebody know something we dont? [SMART MONEY] 11/12/18 12:44:08 PM
#2324   Sounds super juvenile, seems like ihub must mrpickem 11/12/18 12:41:52 PM
#2323   https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142856071 420man 11/12/18 12:29:51 PM
#2322   LOL... Youre insinuation that I don't know how 420man 11/12/18 12:25:52 PM
#2321   they already hit Nasdaq compliance price soo unless rouge Vaughn 11/12/18 12:22:19 PM
#2320   that was a perfect move pick up at rouge Vaughn 11/12/18 12:21:24 PM
#2319   why would there be smh anyways all markets rouge Vaughn 11/12/18 12:20:36 PM
#2318   if you bought this today and did not Attila1905 11/12/18 12:15:00 PM
#2317   There will be a trading investigation in this! 420man 11/12/18 12:14:51 PM
#2316   Yea exaggerate BoilerRoom 11/12/18 12:11:11 PM
#2315   Yep, I usually can spot them because they mrpickem 11/12/18 12:08:41 PM
#2314   lol nah saving a few bucks for when stockyupydowny 11/12/18 12:02:47 PM
#2313   I hope your loading up then, are you mrpickem 11/12/18 12:00:39 PM
#2307   SMH mrpickem 11/12/18 11:42:47 AM
#2306   Incredible dip opportunity - $7+ by EOD stockyupydowny 11/12/18 11:38:33 AM
#2305   No Sir, lots scam artists out there BoilerRoom 11/12/18 11:30:10 AM
#2304   You must be joking right, ha ha ha mrpickem 11/12/18 11:29:27 AM
#2303   Yea you have be careful on these chat boards... BoilerRoom 11/12/18 11:28:45 AM
#2302   Wow, it's so sad some people purposely mislead mrpickem 11/12/18 11:27:56 AM
#2301   Yea today BoilerRoom 11/12/18 11:25:57 AM
#2300   Load up for what?? Going back to $7 mrpickem 11/12/18 11:23:16 AM
#2299   Indeed. Loaded up now. getoffyourass 11/12/18 11:15:53 AM
#2298   And the mojo is gone as i bought Roadtojourney 11/12/18 11:10:15 AM
#2297   Wow look at that selloff from highs Roadtojourney 11/12/18 11:02:06 AM
#2296   $RSLS Load up folks!!!! BoilerRoom 11/12/18 10:58:40 AM
#2295   $RSLS going back to $7.00 BoilerRoom 11/12/18 10:57:45 AM
#2294   $RSLS Weeeeeeeeeeeeeee! BoilerRoom 11/12/18 10:57:17 AM
#2293   Lol yikes Awl416 11/12/18 10:36:15 AM
#2292   https://www.accesswire.com/527754/ReShape-Lifesciences-Completes-Investigator-Me davidsson10 11/12/18 10:14:31 AM
#2291   with a price of 32 to reach i rouge Vaughn 11/12/18 10:09:15 AM
#2290   Nice RSLS need to pull PAC 11/12/18 10:03:22 AM
#2289   Uh oh Awl416 11/12/18 09:56:10 AM
#2288   the numbers speak for itself good luck rouge Vaughn 11/12/18 09:55:57 AM
#2287   %15 green is a gods gift. if you Attila1905 11/09/18 01:03:59 PM
#2286   They'll never get the RS? Yeah! Tell me more. stockmoneybaby 11/09/18 11:37:42 AM
#2285   Dont knpw that many fat veterans. What a hoax! stockmoneybaby 11/09/18 11:25:00 AM
#2284   Happy RS day!! stockmoneybaby 11/09/18 11:22:41 AM
#2283   whats the point of ruining thousands of peoples Attila1905 11/08/18 11:08:24 AM
#2282   Rs approved!!! stockmoneybaby 11/06/18 07:55:11 AM
#2281   What a turd!! stockmoneybaby 11/06/18 07:54:49 AM
#2280   8k- RS approved. martinecko 11/06/18 04:36:35 AM
#2279   Actually, I think it's tied with HMNY for cooler_cat 11/05/18 12:15:24 PM
#2278   OTC soon. The biggest piece of shit on Nasdaq Attila1905 11/05/18 10:16:22 AM
#2277   Just means its time for a bounce. :) getzmuneyactor 11/03/18 04:40:52 PM
#2276   Lol snitches? Cmon ghetto boy stockmoneybaby 11/02/18 05:21:02 PM
#2275   i dont talk to snitches or people that rouge Vaughn 11/02/18 04:40:36 PM
#2274   Waiting for the price to drop further is stockmoneybaby 11/02/18 09:33:40 AM
#2273   waiting on results and quarterly rouge Vaughn 11/02/18 12:49:19 AM
PostSubject